Safety profile of extended-release Niacin/Laropiprant in patients with dyslipiclemia

被引：0
|
作者：
McKenney, James
Bays, Harold
Koren, Michael J.
Ballantyne, Christie
Maccubbin, Darbie
Mitchel, Yale
Betteridge, Abigaile
Kuznetsova, Olga
Sapre, Aditi
Sisk, Christine McCrary
Paolini, John F.
机构：
[1] Virginia Commonwealth Univ, Richmond, VA USA
[2] Merck Res Labs, Rahway, NJ USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2008年 / 51卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A334 / A334
页数：1
相关论文
共 50 条
  • [41] Niacin Extended-Release/Simvastatin
    Mark Sanford
    Monique P. Curran
    Drugs, 2008, 68 : 2373 - 2386
  • [42] Niacin Extended-Release/Simvastatin
    Sanford, Mark
    Curran, Monique P.
    DRUGS, 2008, 68 (16) : 2373 - 2386
  • [43] Extended-Release Niacin/Laropiprant: Reducing Niacin-Induced Flushing to Better Realize the Benefit of Niacin in Improving Cardiovascular Risk Factors
    Paolini, John F.
    Bays, Harold E.
    Ballantyne, Christie M.
    Davidson, Michael
    Pasternak, Richard
    Maccubbin, Darbie
    Norquist, Josephine M.
    Lai, Eseng
    Waters, M. Gerard
    Kuznetsova, Olga
    Sisk, Christine McCrary
    Mitchel, Yale B.
    CARDIOLOGY CLINICS, 2008, 26 (04) : 547 - 560
  • [44] Blood Pressure-Lowering Effects of Extended-Release Niacin Alone and Extended-Release Niacin/Laropiprant Combination: A Post Hoc Analysis of a 24-Week, Placebo-Controlled Trial in Dyslipidemic Patients
    Bays, Harold E.
    Maccubbin, Darbie
    Meehan, Alan G.
    Kuznetsova, Olga
    Mitchel, Yale B.
    Paolini, John F.
    CLINICAL THERAPEUTICS, 2009, 31 (01) : 115 - 122
  • [45] Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein(a) in diabetes
    Pan, JQ
    Van, JT
    Chan, E
    Kesala, RL
    Lin, M
    Charles, MA
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (09): : 1120 - 1127
  • [46] EXTENDED-RELEASE NIACIN/LAROPIPRANT LOWERS SERUM PHOSPHORUS LEVELS IN DYSLIPIDEMIC PATIENTS WITH STAGE 3 CHRONIC KIDNEY DISEASE (CKD)
    Ganjoo, Prerna
    Tipping, Diane
    Tershakovec, Andrew M.
    Bostom, Andrew G.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A27 - A27
  • [47] EXTENDED-RELEASE NIACIN NOT PROBLEM FREE
    SIMPSON, T
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (02): : 237 - 237
  • [48] Lipid-altering efficacy and tolerability profile of extended release niacin/laropiprant in patients with primary hypercholesterolemia or mixed hyperlipidemia
    Maccubbin, D.
    Sirah, W.
    Betteridge, A.
    Yu, Q.
    Sisk, C. Mccrary
    Bays, H.
    Olsson, A. G.
    Paolini, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 108 - 108
  • [49] Effects of extended-release niacin on lipid profile and adipocyte biology in patients with impaired glucose tolerance
    Linke, Axel
    Sonnabend, Melanie
    Fasshauer, Mathias
    Hoellriegel, Robert
    Schuler, Gerhard
    Niebauer, Josef
    Stumvoll, Michael
    Blueher, Matthias
    ATHEROSCLEROSIS, 2009, 205 (01) : 207 - 213
  • [50] Lipid-Altering Efficacy and Safety Profile of Co-Administered Extended Release Niacin/Laropiprant and Simvastatin Versus Atorvastatin in Patients With Mixed Hyperlipidemia
    Chen, Fabian
    Maccubbin, Darbie
    Yan, Lizhen
    Chen, Erluo
    Sisk, Christine Mccrary
    Mckenney, James
    Davidson, Michael
    Blomqvist, Peder
    CIRCULATION, 2011, 124 (21)
12345